Results 281 to 290 of about 1,854,049 (378)

Effect of glutamine on TGF-beta 1 in oral mucositis

Fatma E. A. Hassanein
openalex   +1 more source

Oral Administration of Freeze‐Dried Lactobacillus zeae Alleviates Periodontitis by Affecting the Oral and Intestinal Flora

Food Science &Nutrition, Volume 14, Issue 2, February 2026.
First, probiotic strain Lactobacillus zeae N165 with oral antibacterial activity, autoaggregation ability and coaggregation ability was screened through in vitro experiments. Then, in vivo efficacy evaluation was conducted on this strain, and a mouse model was used to verify its ameliorative effect on periodontitis.
Qimeng Liang, Zixin Kang, Xiaodong Song, Yuanhong Xie, Hongxing Zhang, Junhua Jin   +5 more
wiley   +1 more source

Circulating miR-18b-3p is a novel biomarker predicting chemo-radiotherapy induced oral mucositis in head and neck cancer. [PDF]

Signal Transduct Target Ther
Pulito C, Brandi R, Sestito R, Orlandi G, Sanguineti G, Blandino G, Strano S.   +6 more
europepmc   +1 more source

Efficacy of Cryotherapy on Oral Mucositis Prevention among Patients with Head and Neck Cancers Who Undergoing Radiotherapy

, 2015
Iosr Journals, Gehan. H. Soliman, Omima Said M. H. Shehata   +2 more
openalex   +1 more source

Longitudinal Patterns of Radiation‐Associated Dysphagia in Patients With Head and Neck Cancer: A Systematic Review

Head &Neck, Volume 48, Issue 2, Page 597-623, February 2026.
ABSTRACT Objective To investigate the diagnostic profile of early (i.e., < 6 months of treatment) and late (i.e., ≥ 6 months of treatment) radiation‐associated dysphagia (RAD) in patients with head and neck cancer. Materials and Methods The literature was queried from inception to July 19, 2024.
Anuja H. Shah, Megan T. Nguyen, Shaun A. Nguyen, Justin C. Pelic, Kate Davidson, Ashli K. O'Rourke   +5 more
wiley   +1 more source

Feasibility Study of a Novel Stent-Based Low-Level Laser Therapy Device for Reducing Severe Radiation-Induced Oral Mucositis. [PDF]

Lasers Surg Med
Baek JY, Yang K, Lee TH, Lee SU, Moon SH, Jo IY, Eom KY, Oh D.   +7 more
europepmc   +1 more source

Review of Oral Mucositis Studies in Post Stem Cell Transplant Patients

, 2018
Dilek Yıldırım, Dilek Baykal, Gülbeyaz Can   +2 more
openalex   +1 more source

Triple HER2 Blockade With Trastuzumab, Pertuzumab, and Pyrotinib Versus Dual HER2 Blockade in the Neoadjuvant Treatment of HER2‐Positive Breast Cancer: A Randomized, Phase II Study

MedComm, Volume 7, Issue 2, February 2026.
Triple HER2 blockade with trastuzumab, pertuzumab, and pyrotinib (TPPy) did not improve total pathological complete response (tpCR) rates or breast pathological complete response (bpCR) rates compared with dual blockade with trastuzumab and pertuzumab (TP), but was associated with greater grade ≥ 3 toxicity, particularly diarrhea.
Jiahui Huang, Haoyu Wang, Yiwei Tong, Jin Hong, Yifei Zhu, Weili Ren, Jing Yu, Haoting Shi, Weiqi Gao, Siji Zhu, Jiayi Wu, Ou Huang, Jing Li, Jianrong He, Weiguo Chen, Yafen Li, Kunwei Shen, Xiaosong Chen   +17 more
wiley   +1 more source

Relationship Between Anthracycline-cyclophosphamide Regimens and Docetaxel Monotherapy in Oral Mucositis Development. [PDF]

In Vivo
Saito Y, Sakamoto T, Takekuma Y, Takahashi M, Oshino T, Sugawara M.   +5 more
europepmc   +1 more source

Effectiveness and Safety of Radium‐223 for Bone‐Metastatic Castration‐Resistant Prostate Cancer: The KYUCOG‐1901 Study

Cancer Science, Volume 117, Issue 2, Page 501-510, February 2026.
The KYUCOG‐1901 prospective multicenter study evaluated radium‐223 in 93 Japanese patients with bone‐metastatic castration‐resistant prostate cancer. Ra‐223 was well tolerated, produced meaningful declines in ALP, and yielded a median overall survival of 23.0 months. Early initiation in patients with lower disease burden and integration with subsequent
Masaki Shiota, Shuichi Tatarano, Tomomi Kamba, Toshiyuki Kamoto, Tsukasa Igawa, Naoya Masumori, Hirotsugu Uemura, Kensuke Mitsunari, Takayuki Sumiyoshi, Hiroji Uemura, Katsuyoshi Higashijima, Shoji Tokunaga, Masatoshi Eto   +12 more
wiley   +1 more source